OncLive and The Ruesch Center Announce the Inaugural Luminary Awards in Gastrointestinal Cancer

Article

The first annual Luminary Awards in GI Cancers honoring five outstanding individuals who have devoted their time, talent and resources to improving the care for patients and families affected by GI cancers, will be presented Friday, Dec. 1 at the 8th Annual Ruesch Center Symposium: Fighting a Smarter War on Cancer in Washington.

John L. Marshall, MD

The first annual Luminary Awards in GI Cancers honoring five outstanding individuals who have devoted their time, talent and resources to improving the care for patients and families affected by GI cancers, will be presented Friday, Dec. 1 at the 8th Annual Ruesch Center Symposium: Fighting a Smarter War on Cancer in Washington.

The 2017 awards, presented by The Ruesch Center and OncLive®, celebrates renowned clinicians, researchers, patients and advocates. The winners will be selected from the following five categories:

  • Oncology
  • Gastroenterology
  • Basic science
  • Surgery
  • Philanthropy

“It is an incredible opportunity and a privilege for the Ruesch Center to co-host The Luminary Awards in GI Cancers and publicly recognize for their commitment and leadership in research, clinical care and advocacy in GI cancers. Our partnership with OncLive was essential to bringing this event from concept to reality, said John L. Marshall, MD, director of the Ruesch Center for the Cure of Gastrointestinal Cancers.”

“Our collaboration with The Ruesch Center for The Luminary Awards in GI Cancers enables us to honor talented and inspiring medical professionals and philanthropists, who have contributed toward advancing GI research. We are deeply committed to supporting these individuals who make a difference every day. We look forward to dedicating an evening to these inspiring individuals,” said Michael J. Hennessy Jr., president of Michael J. Hennessy Associates, Inc., parent company of OncLive®.

The Ruesch Center for the Cure of Gastrointestinal Cancers, a part of the Georgetown Lombardi Comprehensive Cancer Center, focuses on personalized patient care, while fighting GI cancers. The Ruesch Center provides the highest standard of care and individualized treatments through clinical trials and research, education and advocacy, and regional and global alliances.

About OncLive®

Contacts

For more information about the awards and the symposium, please visit https://ruesch.georgetown.edu/2017symposium.A digital platform of resources for practicing oncologists, OncLive.com offers oncology professionals information they can use to help provide the best patient care. OncLive® is the official website for Michael J. Hennessy Associates’ Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News®, Oncology Business Management™ and more. Michael J. Hennessy Associates, Inc. is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.For OncLive®

Theresa Burek, 609-716-7777 ext. 811

tburek@mjhassoc.com

Surabhi Verma, 609-716-7777 ext. 851

sverma@mjhassoc.com

Related Videos
A panel of 6 experts on colorectal cancer
A panel of 6 experts on colorectal cancer
Corey Cutler, MD, MPH, and Hana Safah, MD, experts on GvHD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD